Delivery Order SPE2DB25D3005-SPE2DB25FQBPL
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,768.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a completion date of January 28, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition.
Amerisourcebergen...
This federal contract award, valued at $1,768.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product XCOPRI 150 MG TABLET 30S, with a firm fixed-price pricing type and an ultimate completion date of December 20, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,536.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract, with a Firm Fixed Price pricing type, and an ultimate completion date of January 24, 2025. The contract covers the procurement of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a...
This federal contract award, valued at $5,600.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product XCOPRI 150 MG TABLET 30S, with a completion date of January 23, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,771.51, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product XCOPRI 200 MG TABLET 30S, with a period of performance through April 23, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,073.76, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 10, 2025. This contract award is not designated as a set-aside. In addition to this Delivery Order,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,093.79 firm fixed-price delivery order contract covers the provision of the drug XCOPRI 50 MG TABLET 30S, which is likely a specialty medication. The award has an ultimate completion date of January 22, 2025.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
This federal contract award of $8,057.09 was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 14, 2025. The award supports the supply of the medication XCOPRI 50 MG TABLET 30S to the DLA, which plays a critical role in providing medical products to federal government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,065.03 firm fixed-price delivery order is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and does not utilize any set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,702.63, is a Firm Fixed Price Delivery Order for the pharmaceutical product XCOPRI 100 MG TABLET 30S. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...